STAT3 and focal segmental glomerulosclerosis: It was shown that EVs may contribute to FSGS pathogenesis and progression as EVs from FSGS patients stimulate mesangial cell proliferation and upregulate the signal transducer and activator of transcription 3 (STAT-3) pathway [104].